Virtus Biotech ETF (BBP)

Assets	$91.50M
Expense Ratio	0.34%
PE Ratio	n/a
Shares Out	900,004
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	3,618
Open	88.47
Previous Close	88.06
Day's Range	87.01 - 88.47
52-Week Low	57.61
52-Week High	90.42
Beta	0.57
Holdings	61
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus Biotech ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

28.12% of assets

Name	Symbol	Weight
ImmunityBio, Inc.	IBRX	4.92%
Iovance Biotherapeutics, Inc.	IOVA	3.03%
Axsome Therapeutics, Inc.	AXSM	2.82%
Moderna, Inc.	MRNA	2.77%
Legend Biotech Corporation	LEGN	2.63%
TG Therapeutics, Inc.	TGTX	2.58%
Mirum Pharmaceuticals, Inc.	MIRM	2.50%
Travere Therapeutics, Inc.	TVTX	2.44%
Roivant Sciences Ltd.	ROIV	2.22%
Novavax, Inc.	NVAX	2.21%

Performance

BBP had a total return of 45.95% in the past year, including dividends. Since the fund's inception, the average annual return has been 11.14%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Jun 17, 2026

Data Sources Report a data error